Software Package offers image characterization.
Press Release Summary:
ClearLook(TM) is used with Radiologist Review Station, which presents breast images marked to show suspicious features on display screen. It offers full-image, high-resolution zoom capabilities to allow radiologist to enlarge any area of breast image presented. ClearLook provides descriptive data related to masses and calcifications in region of interest, helping to recognize and address early indicators of breast cancer.
Original Press Release:
iCAD Releases ClearLook(TM) - CAD Image Characterization Package
NASHUA, N.H., Dec. 22 - iCAD, Inc. (NASDAQ:ICAD), which designs, develops and markets Computer Aided Detection (CAD) imaging technology and systems for the early detection of breast cancer and other medical applications, today announced the release of its ClearLook(TM) CAD Image Characterization Package. ClearLook is used together with iCAD's Radiologist Review Station, which presents breast images marked to show suspicious features on a display screen typically located where mammographic films are read.
ClearLook offers full-image high-resolution zoom capabilities to allow the radiologist to enlarge any area of the breast image presented. ClearLook provides the radiologist descriptive data related to masses and calcifications in the region of interest, helping the radiologist understand why a particular set of features was marked, or not marked, in a CAD study. The ClearLook package, available as an option for the company's Second Look 500(TM) Mammographic CAD systems, will also be available as an option on iCAD's recently announced, category-defining Second Look 300(TM) system for early detection of breast cancer.
"Because ClearLook provides enhanced viewing and hard data related to the pathology in question," said Scott Parr, iCAD's President & CEO, "it provides additional support to the physician in recognizing and addressing early indicators of breast cancer. This is a feature our customers have requested," continued Parr, "and we feel we have responded with a superior tool for use in interpretation of screening mammograms.
About iCAD, Inc.
iCAD engineers, develops, manufactures and markets computer aided detection (CAD) products for the early detection of breast cancer and other health-care related applications. Selected for the third time as the "Winning Combination of User Satisfaction and Price" by MD Buyline, and this year's recipient of Frost & Sullivan's "Growth Strategy Leadership Award," iCAD is the only independent, integrated digitizer hardware and CAD software company offering computer aided detection solutions. As such, iCAD is able to reduce costs at each step in the CAD product design, production and assembly process. The Company believes its vertical integration of CAD and hardware development results in better integration of software and film digitizer components, lower production costs and reduced administrative overhead. These achievements have allowed iCAD to progressively enhance its CAD product line, while reducing the costs of CAD to many customers and allowing more women to realize the benefits inherent in the early detection of breast cancer. More information on iCAD's products can be found at www.icadmed.com.
